Breaking News

Sanofi to Manufacture API for DBV Drug

Will provide scale-up, process validation, and commercial scale supply

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi and DBV Technologies have entered a strategic manufacturing agreement under which Sanofi will produce the API for DBV’s Viaskin. Sanofi will provide scale-up, process validation, and commercial scale supply.   DBV selected Sanofi for its expertise in biologics development and manufacturing in the field of plant extraction and purification of therapeutic proteins. Also, Sanofi’s manufacturing site in Aramon, France, has all the necessary capabilities to support the registration of Viaskin ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters